Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 5
Submit an article Journal homepage
82
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Severe Autoimmune Hemolytic Anemia Following Rituximab Therapy in a Patient with a Lymphoproliferative Disorder

E. Jourdan Service de Médecine Interne B, Hôpital Caremeau, Av du Professeur Robert Debré, F-30900 Nîmes, France
,
D. Topart Service de Médecine Interne B, Hôpital Caremeau, Av du Professeur Robert Debré, F-30900 Nîmes, France
,
B. Richard Service de Médecine Interne B, Hôpital Caremeau, Av du Professeur Robert Debré, F-30900 Nîmes, France
,
J. Jourdan Université Montpellier I, Faculté de Médecine, Montpellier-Nîmes, France
&
A. Sotto Université Montpellier I, Faculté de Médecine, Montpellier-Nîmes, France
Pages 889-890 | Published online: 01 Jul 2009

  • Maloney, D.G., Grillo-Lopez, A.J., While. C.A., Bodkin. D., Schilder, RJ., Neidhart, J.A., Janakiraman. N., Foon, K.A., Lites, T.M., Dallaire. B.K., Wey, K., Royston. L., Daviv T. and Levy, R. (1997) "IDEC-C2B8 (Riluximab anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's Iymphoma", Blood 90(6), 2188-2195.
  • McLaughlin, P., Grillo-Lopez, A.J., Link, B.K., Levy. R., Czuczman. M.S., Williams. ME., Heyman. M.R., Beace-Bruckler. I., White. C.A., Cabanillas, F., Jain. V., Ho, A.D., Lister. J., Wey, K., Shen. D. and Dallaire, B.K. 11998) "Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: hall of patients respond to a four-dose treatment program", Journal of Clinical Oncology 16(8), 2825-2833.
  • Coiflier, B., Haioun, C., Ketterer. N., Engen. A., Tilly, H., Ma. D., Johnson. P., Lister. A., Feuring-Buske. M., Radford, J.A.,Capdeville. R. Diehl. V. and Reyes. A. (1998) "Rituximab (anti-CD20 monoclonal antibixly) for the treatment of patients with relapsing or refractory aggressive lymphonia: a multicenter phase II study", Blood 92(6), 1927-1932.
  • Coiffier, B., Lepage, E., Briere, J., Herbreeht, R., Tilly, H., Bouabdallah, R., Moret, P., Van Den Neste. E., Salles, C., Gaulard, P., Reyes, R. Lederlin. P. and Gisselbrecht. C. (2002) "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell Iymphoma", New England Journal of Medicine 346(4), 235-242.
  • Zaja, F., Iacona, I., Masolini. P., Russo. D., Sperotto. A., Prosdocimo. S., Patriarca. E. DeVita, S., Regazzi, M., Baccarani. M. and Fanin, R. (2002) "B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia", Haeatologica 87(2), 189-195.
  • Matutes, E., Owusu-Ankomah. K., Morilla, R., Garcia Marco. J., Houlihan, A., Que, T.H. and Calovsky. D. (1994) "The immunological profile of B-cell disorders and proposal of scoring system for the diagnosis of CLL", Leukemia 8(10), 1640-1645.
  • Byrd, J.C., While. CA., Link. B., Lucas, M.S., Velasquez. W.S., Rosenberg. J. and Grillo-Lopez. A.J. (1999) "Rituximab therapy in Waldensirom's macroglobulinemia: preliminary evidence of clinical activity", Annals of Oncology 10(12), 1525-1527.
  • Weide, R., Heymanns. J. and Koppler, H. (1999) "Induction of complete haematological remission after monotheropy with antiCD20 monoclonal antibody (RITUXIMAB) in a patient with alkylating agent resistant Waldenslorm's macroglobulinaemia", leukemia and Lymphoma 36(1-2), 203-206.
  • Dimopoulas, M.A., Zervas, C., Zomas. A., Kiamouris. C., Vininou. N.A., Grigoraki. V. Karkantaris, C., Mitsouli. C., Gika. D., Christakis. J. and Anagnostopoulos. N. (2002) "Treatment of Waldenstrom's Macroglobulinemia with Rituximab", Journal of Clinical Oncology 20(9), 2327-2333.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.